Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Edward Carr

Edward Carr is recorded as Chief Accounting Officer and Board Member at Dianthus Therapeutics, Inc. /DE/ (DNTH) and CFO at Abeona Therapeutics Inc. (ABEO). Dianthus Therapeutics, Inc. /DE/ reported in an 8-K filed September 12, 2023 that Edward Carr was appointed Chief Accounting Officer and principal accounting officer, effective September 11, 2023. The proxy statement of Abeona Therapeutics Inc. reports total compensation of $1,569,879 for Edward Carr in fiscal 2021, including a base salary of $360,985. Disclosed compensation is on record for 2 fiscal years. Edward Carr has spoken on 5 earnings calls across 1 company, most recently for Abeona Therapeutics Inc. on November 15, 2021.

“On September 11, 2023, the Board of Directors appointed Marino Garcia as the Company's President and Chief Executive Officer and principal executive officer, Ryan Savitz as the Company's Treasurer and Chief Financial Officer and principal financial officer and Edward Carr as the Company's Chief Accounting Officer and principal accounting officer.”
Dianthus Therapeutics, Inc. /DE/ Form 8-K, filed September 12, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Abeona Therapeutics Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Dianthus Therapeutics, Inc. /DE/

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Abeona Therapeutics Inc. (ABEO) $360,985 $1,569,879
2020 Abeona Therapeutics Inc. (ABEO) $300,000 $924,007

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.